AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2018
Feb 15, 2018
30339_dirs_2018-02-15_d1e1b4fa-e513-427e-bb59-85898f2c04fb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2018-02-13
Reporting Person: MILLER GEORGE LLOYD (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-13 | Common Stock | A | 2785.00 | $93.00 | Acquired | 7403.4554 | Indirect |
| 2018-02-13 | Common Stock | A | 2828.00 | $93.00 | Acquired | 10231.4554 | Indirect |
Footnotes
F1: Bonus & Incentive share grant
F2: 2015 PSU (PP14) award vesting
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12